相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Perioperative Systemic Chemotherapy for Colorectal Liver Metastasis: Recent Updates
Hee Yeon Lee et al.
CANCERS (2021)
A novel topoisomerase I inhibitor DIA-001 induces DNA damage mediated cell cycle arrest and apoptosis in cancer cell
Jiaqi Liu et al.
ANNALS OF TRANSLATIONAL MEDICINE (2020)
Irinotecan-Still an Important Player in Cancer Chemotherapy: A Comprehensive Overview
Mateusz Kciuk et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
COTI-2, A Novel Thiosemicarbazone Derivative, Exhibits Antitumor Activity in HNSCC through p53-dependent and -independent Mechanisms
Antje Lindemann et al.
CLINICAL CANCER RESEARCH (2019)
Current cancer situation in China: good or bad news from the 2018 Global Cancer Statistics?
Rui-Mei Feng et al.
CANCER COMMUNICATIONS (2019)
Antitumor potential of a novel camptothecin derivative, ZBH-ZM-06
Di Wu et al.
ONCOLOGY REPORTS (2018)
A novel oral camptothecin analog, gimatecan, exhibits superior antitumor efficacy than irinotecan toward esophageal squamous cell carcinoma in vitro and in vivo
Jianling Zou et al.
CELL DEATH & DISEASE (2018)
Synthesis and antitumor activity of novel substituted uracil-1′(N)-acetic acid ester derivatives of 20(S)-camptothecins
Di-Zao Li et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2017)
Assessment of the chemotherapeutic potential of a new camptothecin derivative, ZBH-1205
Di Wu et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2016)
Irinotecan chemotherapy combined with fluoropyrimidines versus irinotecan alone for overall survival and progressionfree survival in patients with advanced and/or metastatic colorectal cancer
Wahyu Wulaningsih et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2016)
Synthesis and Biological Evaluation of Novel 10-Substituted-7-ethyl-10-hydroxycamptothecin (SN-38) Prodrugs
Mo Zhou et al.
MOLECULES (2014)
A multinational phase 2 study of nanoliposomal irinotecan sucrosofate (PEP02, MM-398) for patients with gemcitabine-refractory metastatic pancreatic cancer
A. H. Ko et al.
BRITISH JOURNAL OF CANCER (2013)
STK295900, a Dual Inhibitor of Topoisomerase 1 and 2, Induces G2 Arrest in the Absence of DNA Damage
Sun-Ok Kim et al.
PLOS ONE (2013)
A Novel DNA Topoisomerase I Inhibitor with Different Mechanism from Camptothecin Induces G2/M Phase Cell Cycle Arrest to K562 Cells
Ning Wu et al.
BIOCHEMISTRY (2010)
Synthesis, in vitro and in vivo evaluation of 3-arylisoquinolinamines as potent antitumor agents
Su Hui Yang et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2010)
Optimal antidiarrhea treatment for antitumor agent irinotecan hydrochloride (CPT-11)-induced delayed diarrhea
K. Takasuna et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2006)
分享论文
